Equities

Mochida Pharmaceutical Co Ltd

Mochida Pharmaceutical Co Ltd

Actions
  • Price (EUR)19.70
  • Today's Change-0.10 / -0.51%
  • Shares traded0.00
  • 1 Year change-2.48%
  • Beta--
Data delayed at least 15 minutes, as of Nov 12 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Income statement Back to Overview

In millions of JPY
(except for per share items)
Fiscal data as of Mar 31 2024202420232022
REVENUE AND GROSS PROFIT
Total revenue102,885103,261110,179
OPERATING EXPENSES
Cost of revenue total50,81548,14650,626
Selling, general and admin. expenses, total33,71333,32432,866
Depreciation/amortization------
Unusual expense(income)332(13)728
Other operating expenses, total1.001.00--
Total operating expense97,41594,74196,515
Operating income5,4708,52013,664
Other, net100274120
INCOME TAXES, MINORITY INTEREST AND EXTRA ITEMS
Net income before taxes6,1609,04414,591
Provision for income taxes1,6132,3954,022
Net income after taxes4,5476,64910,569
Minority interest------
Net income before extra. Items4,5476,64910,569
Total extraordinary items------
Net income4,5476,64910,569
Inc.avail. to common excl. extra. Items4,5476,64910,569
Inc.avail. to common incl. extra. Items4,5476,64910,569
EPS RECONCILIATION
Basic/primary weighted average shares363738
Basic/primary eps excl. extra items127179277
Basic/primary eps incl. extra items127179277
Dilution adjustment------
Diluted weighted average shares363738
Diluted eps excl. extra items127179277
Diluted eps incl. extra items127179277
COMMON STOCK DIVIDENDS
DPS - common stock primary issue808090
Gross dividend - common stock2,8422,9523,408
PRO FORMA INCOME
Pro forma net income------
Interest expense, supplemental2.000--
SUPPLEMENTAL INCOME
Depreciation, supplemental2,8082,6722,689
Total special items31041733
NORMALISED INCOME
Normalized income before taxes6,4709,08515,324
Effect of special items on income taxes8111202
Income tax excluding impact of special items1,6942,4064,224
Normalized income after tax4,7766,67911,100
Normalized income avail. to common4,7766,67911,100
Basic normalized EPS133180291
Diluted normalized EPS133180291
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.